Works by Chi, Yueh‐Yun

Results: 62
    1
    2
    3
    4
    5

    45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

    Published in:
    2017
    By:
    • Ermoian, Ralph P.;
    • Breneman, John;
    • Walterhouse, David O.;
    • Chi, Yueh‐Yun;
    • Meza, Jane;
    • Anderson, James;
    • Hawkins, Douglas S.;
    • Hayes‐Jordan, Andrea A.;
    • Parham, David M.;
    • Yock, Torunn I.;
    • Donaldson, Sarah S.;
    • Wolden, Suzanne L.;
    • Chi, Yueh-Yun;
    • Hayes-Jordan, Andrea A
    Publication type:
    journal article
    6
    7

    Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group.

    Published in:
    2020
    By:
    • Ehrlich, Peter F.;
    • Chi, Yueh‐Yun;
    • Chintagumpala, Murali M.;
    • Hoffer, Fredric A.;
    • Perlman, Elizabeth J.;
    • Kalapurakal, John A.;
    • Tornwall, Brett;
    • Warwick, Anne;
    • Shamberger, Robert C.;
    • Khanna, Geetika;
    • Hamilton, Thomas E.;
    • Gow, Kenneth W.;
    • Paulino, Arnold C.;
    • Gratias, Eric J.;
    • Mullen, Elizabeth A.;
    • Geller, James I.;
    • Grundy, Paul E.;
    • Fernandez, Conrad V.;
    • Dome, Jeffrey S.;
    • Chi, Yueh-Yun
    Publication type:
    journal article
    8
    9
    10
    11

    Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group.

    Published in:
    2018
    By:
    • Teot, Lisa A.;
    • Schneider, Michaela;
    • Thorner, Aaron R.;
    • Tian, Jing;
    • Chi, Yueh‐Yun;
    • Ducar, Matthew;
    • Lin, Ling;
    • Wlodarski, Marcin;
    • Grier, Holcombe E.;
    • Fletcher, Christopher D. M.;
    • van Hummelen, Paul;
    • Skapek, Stephen X.;
    • Hawkins, Douglas S.;
    • Wagers, Amy J.;
    • Rodriguez‐Galindo, Carlos;
    • Hettmer, Simone;
    • Chi, Yueh-Yun;
    • Rodriguez-Galindo, Carlos
    Publication type:
    journal article
    12
    13
    14

    Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 5, p. 613, doi. 10.1002/ajh.26510
    By:
    • Pommert, Lauren;
    • Schafer, Eric S.;
    • Malvar, Jemily;
    • Gossai, Nathan;
    • Florendo, Ellynore;
    • Pulakanti, Kirthi;
    • Heimbruch, Katelyn;
    • Stelloh, Cary;
    • Chi, Yueh‐Yun;
    • Sposto, Richard;
    • Rao, Sridhar;
    • Huynh, Van Thu;
    • Brown, Patrick;
    • Chang, Bill H.;
    • Colace, Susan I.;
    • Hermiston, Michelle L.;
    • Heym, Kenneth;
    • Hutchinson, Raymond J.;
    • Kaplan, Joel A.;
    • Mody, Rajen
    Publication type:
    Article
    15
    16
    17

    Metabolic response as assessed by <sup>18</sup>F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee

    Published in:
    Cancer Medicine, 2021, v. 10, n. 3, p. 857, doi. 10.1002/cam4.3667
    By:
    • Harrison, Douglas J.;
    • Chi, Yueh‐Yun;
    • Tian, Jing;
    • Hingorani, Pooja;
    • Mascarenhas, Leo;
    • McCowage, Geoffrey B.;
    • Weigel, Brenda J.;
    • Venkatramani, Rajkumar;
    • Wolden, Suzanne L.;
    • Yock, Torunn I.;
    • Rodeberg, David A.;
    • Hayes‐Jordan, Andrea A.;
    • Teot, Lisa A.;
    • Spunt, Sheri L.;
    • Meyer, William H.;
    • Hawkins, Douglas S.;
    • Shulkin, Barry L.;
    • Parisi, Marguerite T.
    Publication type:
    Article
    18

    Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 14, p. 6437, doi. 10.1002/cam4.2504
    By:
    • Hibbitts, Emily;
    • Chi, Yueh‐Yun;
    • Hawkins, Douglas S.;
    • Barr, Frederic G.;
    • Bradley, Julie A.;
    • Dasgupta, Roshni;
    • Meyer, William H.;
    • Rodeberg, David A.;
    • Rudzinski, Erin R.;
    • Spunt, Sheri L.;
    • Skapek, Stephen X.;
    • Wolden, Suzanne L.;
    • Arndt, Carola A. S.
    Publication type:
    Article
    19

    Multivariate methods.

    Published in:
    WIREs: Computational Statistics, 2012, v. 4, n. 1, p. 35, doi. 10.1002/wics.185
    By:
    • Chi, Yueh-Yun
    Publication type:
    Article
    20
    21

    Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial.

    Published in:
    Pediatric Blood & Cancer, 2025, v. 72, n. 5, p. 1, doi. 10.1002/pbc.31584
    By:
    • Shah, Nirali N.;
    • Schafer, Eric S.;
    • Chi, Yueh‐Yun;
    • Malvar, Jemily;
    • Heym, Kenneth M.;
    • Place, Andrew E.;
    • Burns, Melissa;
    • Chang, Bill H.;
    • Slone, Tamra;
    • Verma, Anupam;
    • Gossai, Nathan;
    • Shaw, Peter H.;
    • Burke, Michael J.;
    • Hermiston, Michelle;
    • Schore, Reuven J.;
    • Cooper, Todd;
    • Pauly, Melinda;
    • Rushing, Teresa;
    • Jarosinski, Paul;
    • Florendo, Ellynore
    Publication type:
    Article
    22
    23

    Survival of pediatric Hodgkin lymphoma patients treated with doxorubicin, bleomycin, vincristine, etoposide, prednisone, and cyclophosphamide (ABVE‐PC) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) at a single institution.

    Published in:
    Pediatric Blood & Cancer, 2022, v. 69, n. 5, p. 1, doi. 10.1002/pbc.29601
    By:
    • de Armas, Sebastian;
    • Huertas‐Ayala, Carolina;
    • Chan, Randall Y.;
    • Chi, Yueh‐Yun;
    • Huh, Winston W.;
    • Termuhlen, Amanda;
    • Gaynon, Paul S.;
    • Kovach, Alexandra E.;
    • Doan, Andrew
    Publication type:
    Article
    24

    Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups.

    Published in:
    Pediatric Blood & Cancer, 2021, v. 68, n. 3, p. 1, doi. 10.1002/pbc.28832
    By:
    • Gallego, Soledad;
    • Chi, Yueh‐Yun;
    • De Salvo, Gian Luca;
    • Li, Minjie;
    • Merks, Johannes H.M.;
    • Rodeberg, David A.;
    • Scheltinga, Sheila Terwisscha;
    • Mascarenhas, Leo;
    • Orbach, Daniel;
    • Jenney, Meriel;
    • Million, Lynn;
    • Minard‐Colin, Veronique;
    • Wolden, Suzanne;
    • Zanetti, Ilaria;
    • Parham, David M.;
    • Mandeville, Henry;
    • Venkatramani, Rajkumar;
    • Bisogno, Gianni;
    • Hawkins, Douglas S.
    Publication type:
    Article
    25
    26
    27

    Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534).

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 13, p. 2493, doi. 10.1002/cncr.34219
    By:
    • Chintagumpala, Murali M.;
    • Perlman, Elizabeth J.;
    • Tornwall, Brett;
    • Chi, Yueh‐Yun;
    • Kim, Yeonil;
    • Hoffer, Fredric A.;
    • Kalapurakal, John A.;
    • Warwick, Anne B.;
    • Shamberger, Robert C.;
    • Khanna, Geetika;
    • Hamilton, Thomas E.;
    • Gow, Kenneth W.;
    • Paulino, Arnold C.;
    • Gratias, Eric J.;
    • Mullen, Elizabeth A.;
    • Geller, James I.;
    • Fernandez, Conrad V.;
    • Ritchey, Michael L.;
    • Grundy, Paul E.;
    • Dome, Jeffrey S.
    Publication type:
    Article
    28

    Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 11, p. 1721, doi. 10.1093/jnci/djae165
    By:
    • Schafer, Eric S;
    • Rushing, Teresa;
    • Crews, Kristine R;
    • Annesley, Colleen;
    • Colace, Susan I;
    • Kaiser, Nicole;
    • Pommert, Lauren;
    • Ramsey, Laura B;
    • Sabnis, Himalee S;
    • Wong, Kenneth;
    • Chang, Bill H;
    • Cooper, Todd M;
    • Shah, Nirali N;
    • Rheingold, Susan R;
    • Place, Andrew E;
    • Chi, Yueh-Yun;
    • Bhojwani, Deepa;
    • Wayne, Alan S;
    • Bernhardt, M Brooke
    Publication type:
    Article
    29
    30

    Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47057-2
    By:
    • Keller, Michael D.;
    • Hanley, Patrick J.;
    • Chi, Yueh-Yun;
    • Aguayo-Hiraldo, Paibel;
    • Dvorak, Christopher C.;
    • Verneris, Michael R.;
    • Kohn, Donald B.;
    • Pai, Sung-Yun;
    • Dávila Saldaña, Blachy J.;
    • Hanisch, Benjamin;
    • Quigg, Troy C.;
    • Adams, Roberta H.;
    • Dahlberg, Ann;
    • Chandrakasan, Shanmuganathan;
    • Hasan, Hasibul;
    • Malvar, Jemily;
    • Jensen-Wachspress, Mariah A.;
    • Lazarski, Christopher A.;
    • Sani, Gelina;
    • Idso, John M.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37

    Haplotype-resolved germline and somatic alterations in renal medullary carcinomas.

    Published in:
    Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00929-4
    By:
    • Tan, Kar-Tong;
    • Kim, Hyunji;
    • Carrot-Zhang, Jian;
    • Zhang, Yuxiang;
    • Kim, Won Jun;
    • Kugener, Guillaume;
    • Wala, Jeremiah A.;
    • Howard, Thomas P.;
    • Chi, Yueh-Yun;
    • Beroukhim, Rameen;
    • Li, Heng;
    • Ha, Gavin;
    • Alper, Seth L.;
    • Perlman, Elizabeth J.;
    • Mullen, Elizabeth A.;
    • Hahn, William C.;
    • Meyerson, Matthew;
    • Hong, Andrew L.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43

    Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 5, p. 788, doi. 10.1038/s41416-023-02525-2
    By:
    • Hogarty, Michael D.;
    • Ziegler, David S.;
    • Franson, Andrea;
    • Chi, Yueh-Yun;
    • Tsao-Wei, Denice;
    • Liu, Kangning;
    • Vemu, Rohan;
    • Gerner, Eugene W.;
    • Bruckheimer, Elizabeth;
    • Shamirian, Anasheh;
    • Hasenauer, Beth;
    • Balis, Frank M.;
    • Groshen, Susan;
    • Norris, Murray D.;
    • Haber, Michelle;
    • Park, Julie R.;
    • Matthay, Katherine K.;
    • Marachelian, Araz
    Publication type:
    Article
    44

    Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium.

    Published in:
    Cancers, 2024, v. 16, n. 3, p. 496, doi. 10.3390/cancers16030496
    By:
    • Verma, Anupam;
    • Chi, Yueh-Yun;
    • Malvar, Jemily;
    • Lamble, Adam;
    • Chaudhury, Sonali;
    • Agarwal, Archana;
    • Li, Hong-Tao;
    • Liang, Gangning;
    • Leong, Roy;
    • Brown, Patrick A.;
    • Kaplan, Joel;
    • Schafer, Eric S.;
    • Slone, Tamra;
    • Pauly, Melinda;
    • Chang, Bill H.;
    • Stieglitz, Elliot;
    • Wayne, Alan S.;
    • Hijiya, Nobuko;
    • Bhojwani, Deepa
    Publication type:
    Article
    45
    46
    47
    48
    49
    50